Case Name (Date)

Lomedico et al. v. American Behavioral Research Institute LLC, d/b/a Relaxium
22-cv-6097, S.D.N.Y.
(July 2022)


Product/Service

Relaxium


Allegations

Misleadingly marketing that the supplement is a “clinically proven” sleep aid when the only scientific study conducted on the product was inadequate and sponsored by Relaxium

Falsely advertising that the supplement was developed by a “sleep expert” when he has no experience or background in treating sleep disorders


Status

Settled



The Latest

Filters

TINA.org Files FTC Complaint against Homeaglow

Press Release

TINA.org Files FTC Complaint against Homeaglow

MADISON, CONN. Sept. 9, 2025 – An investigation by consumer advocacy organization truthinadvertising.org (TINA.org) has found that Homeaglow is deceptively advertising $19 home cleanings in order to lure consumers into…


Show More